Summary Physiomics plc (Physiomics) is a computational systems biology services company. It is involved in developing outsourced systems and computational systems biology models for predicting and understanding cancer drug efficacy from pre-clinical research to clinical development and finding optimal schedules. The company provides consulting services for specific pharmaceutical development projects and provides trouble-shooting services for cancer projects in exchange for product licenses and royalties. Its key services include designing optimal drug schedules, optimizing drug combinations, and single-blind validation study. The company is also involved in developing Virtual Tumour Clinical; cardiac tox prediction service; and drug combination database. Physiomics partners with small and large pharmaceutical and biotechnology companies which include Eli Lilly, Sareum, Cyclacel Pharmaceutical, Institute of Cancer Research, Cancer Research Technology, Bayer Technology Services GmbH and ValiRx. Physiomics is headquartered at Oxford, the UK. Physiomics Plc (PYC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions,... Research Beam Model: Research Beam Product ID: 2136298 250 USD New
Physiomics Plc (PYC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Physiomics Plc (PYC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : September   2017
  • Pages : 35
  • Publisher : GlobalData
 
 
 
Summary

Physiomics plc (Physiomics) is a computational systems biology services company. It is involved in developing outsourced systems and computational systems biology models for predicting and understanding cancer drug efficacy from pre-clinical research to clinical development and finding optimal schedules. The company provides consulting services for specific pharmaceutical development projects and provides trouble-shooting services for cancer projects in exchange for product licenses and royalties. Its key services include designing optimal drug schedules, optimizing drug combinations, and single-blind validation study. The company is also involved in developing Virtual Tumour Clinical; cardiac tox prediction service; and drug combination database. Physiomics partners with small and large pharmaceutical and biotechnology companies which include Eli Lilly, Sareum, Cyclacel Pharmaceutical, Institute of Cancer Research, Cancer Research Technology, Bayer Technology Services GmbH and ValiRx. Physiomics is headquartered at Oxford, the UK.

Physiomics Plc (PYC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Physiomics Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Physiomics Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Physiomics Plc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Physiomics Partners with Pharma Company 10
Physiomics Plans to Enter into Co-Development Agreement with Diatech Pharmacogenetics 11
Physiomics Enters Into Agreement With Jubilant BioSys To Offer Services In Oncology Field 12
ValiPharma Enters Into Co-Development Agreement With Physiomics 13
Physiomics Enters Into Collaboration With Pharmacometrics 14
Equity Offering 15
Physiomics Raises USD0.7 Million in Private Placement of Shares 15
Physiomics Raises USD0.4 Million in Private Placement of Shares 16
Physiomics Raises USD0.4 Million in Private Placement of Shares 17
Physiomics Raises USD0.9 Million in Private Placement 18
Physiomics Announces Private Placement Of Shares For US$6.3 Million 19
Physiomics Completes Private Placement Of US$0.97 Million 20
Physiomics Plc - Key Competitors 21
Physiomics Plc - Key Employees 22
Physiomics Plc - Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Financial Announcements 24
Mar 24, 2017: Physiomics Announces Interim Results Statement for the six month period ended 31 December 2016 24
Oct 27, 2016: Physiomics: Final Results for the year ended 30 June 2016 26
Oct 25, 2016: Physiomics Announces Change of Director 28
Mar 31, 2016: Interim Results Statement for the six month period ended 31 December 2015 29
Corporate Communications 31
Apr 18, 2016: Physiomics Appoints a New Chief Executive Officer 31
Government and Public Interest 32
Jan 06, 2017: Physiomics: Confirmation of Award of Innovate UK Grant 32
Other Significant Developments 33
May 24, 2017: Physiomics Provides Update on Two Further Extension Projects to Advance Oncology Candidate With Global Pharma Company 33
Jan 11, 2017: Physiomics: Company Update 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
List of Tables
Physiomics Plc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Physiomics Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Physiomics Plc, Deals By Therapy Area, 2011 to YTD 2017 8
Physiomics Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Physiomics Partners with Pharma Company 10
Physiomics Plans to Enter into Co-Development Agreement with Diatech Pharmacogenetics 11
Physiomics Enters Into Agreement With Jubilant BioSys To Offer Services In Oncology Field 12
ValiPharma Enters Into Co-Development Agreement With Physiomics 13
Physiomics Enters Into Collaboration With Pharmacometrics 14
Physiomics Raises USD0.7 Million in Private Placement of Shares 15
Physiomics Raises USD0.4 Million in Private Placement of Shares 16
Physiomics Raises USD0.4 Million in Private Placement of Shares 17
Physiomics Raises USD0.9 Million in Private Placement 18
Physiomics Announces Private Placement Of Shares For US$6.3 Million 19
Physiomics Completes Private Placement Of US$0.97 Million 20
Physiomics Plc, Key Competitors 21
Physiomics Plc, Key Employees 22List of Figures
Physiomics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Physiomics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter